Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1998 3
1999 3
2001 3
2002 1
2003 1
2004 1
2005 4
2006 5
2007 2
2008 4
2009 3
2010 4
2011 3
2012 4
2013 6
2014 12
2015 7
2016 7
2017 8
2018 12
2019 16
2020 6
2021 9
2022 15
2023 7
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M; INBUILD trial investigators. Wells AU, et al. Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5. Lancet Respir Med. 2020. PMID: 32145830 Clinical Trial.
COPD immunopathology.
Caramori G, Casolari P, Barczyk A, Durham AL, Di Stefano A, Adcock I. Caramori G, et al. Among authors: barczyk a. Semin Immunopathol. 2016 Jul;38(4):497-515. doi: 10.1007/s00281-016-0561-5. Epub 2016 May 13. Semin Immunopathol. 2016. PMID: 27178410 Free PMC article. Review.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
West A, Chaudhuri N, Barczyk A, Wilsher ML, Hopkins P, Glaspole I, Corte TJ, Šterclová M, Veale A, Jassem E, Wijsenbeek MS, Grainge C, Piotrowski W, Raghu G, Shaffer ML, Nair D, Freeman L, Otto K, Montgomery AB. West A, et al. Among authors: barczyk a. Thorax. 2023 Sep;78(9):882-889. doi: 10.1136/thorax-2022-219391. Epub 2023 Mar 22. Thorax. 2023. PMID: 36948586 Free article. Clinical Trial.
Advances in Respiratory Medicine-Aims and Scopes Update.
Kuziemski K, Franczuk M, Majewski S, Zielonka TM, Barczyk A. Kuziemski K, et al. Among authors: barczyk a. Adv Respir Med. 2024 Mar 19;92(2):156-157. doi: 10.3390/arm92020017. Adv Respir Med. 2024. PMID: 38525776 Free PMC article.
A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB Study.
Majewski S, Białas AJ, Barczyk A, Batura-Gabryel H, Buchczyk M, Doboszyńska A, Górska K, Grabowska-Skudlarz L, Jagielska-Len H, Jarzemska A, Jassem E, Jastrzębski D, Kania A, Koprowski M, Krawczyk M, Krenke R, Lewandowska K, Mackiewicz B, Martusewicz-Boros MM, Milanowski J, Noceń-Piskorowska M, Nowicka A, Roszkowski-Śliż K, Siemińska A, Sładek K, Sobiecka M, Stachura T, Tomczak M, Tomkowski W, Trzaska-Sobczak M, Ziora D, Żołnowska B, Piotrowski WJ. Majewski S, et al. Among authors: barczyk a. J Clin Med. 2023 Jul 12;12(14):4635. doi: 10.3390/jcm12144635. J Clin Med. 2023. PMID: 37510750 Free PMC article.
Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study.
Barczyk A, Czajkowska-Malinowska M, Farnik M, Barczyk M, Boda Ł, Cofta S, Duława J, Dyrbuś M, Harat R, Huk M, Kotecka S, Nahorecki A, Nasiłowski J, Naumnik W, Przybylski G, Słaboń-Willand M, Skoczyński S, Wita K, Zioło G, Kuna P. Barczyk A, et al. Respir Med. 2023 Jun;212:107198. doi: 10.1016/j.rmed.2023.107198. Epub 2023 Mar 15. Respir Med. 2023. PMID: 36931576 Free PMC article. Clinical Trial.
146 results